GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
51.71
-2.77 (-5.08%)
Apr 29, 2026, 11:45 AM EDT - Market open
GSK Revenue
GSK had revenue of 7.63B GBP in the quarter ending March 31, 2026, with 1.50% growth. This brings the company's revenue in the last twelve months to 32.78B, up 3.97% year-over-year. In the year 2025, GSK had annual revenue of 32.67B with 4.11% growth.
Revenue (ttm)
32.78B GBP
Revenue Growth
+3.97%
P/S Ratio
2.53
Revenue / Employee
490,418 GBP
Employees
66,841
Market Cap
109.34B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.67B | 1.29B | 4.11% |
| Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
| Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
| Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
| Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck & Co. | 65.01B |
| Pfizer | 62.58B |
| AbbVie | 61.16B |
| AstraZeneca | 58.74B |
| Novartis AG | 56.58B |
| Sanofi | 54.60B |
| Novo Nordisk | 48.59B |
| Bristol-Myers Squibb Company | 48.19B |
GSK News
- 3 hours ago - GSK Reports Strong Q1 2026 Results with Revenue Growth - GuruFocus
- 3 hours ago - GSK Declares Quarterly Dividend of $0.44, Initiates £2 Billion Buyback - GuruFocus
- 3 hours ago - GSK Raises 2031 Sales Forecast to Over GBP 40 Billion - GuruFocus
- 4 hours ago - GSK Expects Steady Growth Through 2026 - GuruFocus
- 4 hours ago - GSK Reports Strong Q1 Sales Growth and Advancements in R&D - GuruFocus
- 4 hours ago - AstraZeneca (AZN) and GlaxoSmithKline (GSK) Exceed Q1 Earnings Expectations - GuruFocus
- 4 hours ago - Shot in the arm for GSK and AstraZeneca from cancer drug sales - Evening Standard
- 4 hours ago - GSK plc Earnings Call Transcript: Q1 2026 - Transcripts